OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
October 01, 2020
Drug shortages and supply chain challenges bolster FDA efforts to promote modern manufacturing.
September 01, 2020
Regulators strive to review flood of advanced treatments while also vetting COVID-19 vaccines.
August 24, 2020
FDA announced it had issued an emergency use authorization for convalescent plasma that would make it easier to provide this treatment to COVID-19 patients.
July 01, 2020
FDA can better monitor quality production of domestic versus foreign firms.
June 01, 2020
FDA and the US Congress support innovation and access to cheaper medicines.
May 01, 2020
Policy makers seek to ensure supplies of new therapies and to limit shortages.
April 01, 2020
FDA is encouraging alternative insulins and challenging anticompetitive practices.
March 01, 2020
States, hospitals, and insurers support manufacturing arrangements to ensure access to affordable medicines.
February 01, 2020
Increased reliance on foreign producers raises concerns and spurs collaborations.
January 01, 2020
Pressures on FDA will affect industry’s success in bringing new therapies to market.